Figure 2
(A) Progression-free survival in first-line chemotherapy, analysed by BRAF mutation status. (B) Overall survival, analysed by BRAF mutation status.
Figure 2 | British Journal of Cancer
(A) Progression-free survival in first-line chemotherapy, analysed by BRAF mutation status. (B) Overall survival, analysed by BRAF mutation status.
